Core Viewpoint - Hainan Shuangcheng Pharmaceutical Co., Ltd. has recently obtained a revised Drug Production License from the Hainan Provincial Drug Administration, allowing the company to undertake contract manufacturing of injectable Etoposide Sodium (1.0g specification) for Shanghai Mengke Pharmaceutical Co., Ltd. [1][2] Group 1 - The revised Drug Production License includes the addition of contract manufacturing information, which will help the company optimize its production structure and meet market demand [2] - The production address and facilities are located at No. 16, Xingguo Road, Xiuying District, Haikou City, with a production line specifically for freeze-dried powder injections [1] - The license is valid until August 7, 2030, and covers a range of products including raw materials and various types of injectable formulations [1][2]